Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: Rapid response to imatinib mesylate (STI571)IMASHUKU, Shinsaku; MORIMOTO, Akira; KURIYAMA, Kikuko et al.Medical and pediatric oncology. 2003, Vol 41, Num 2, pp 159-160, issn 0098-1532, 2 p.Article

Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disordersTSIMBERIDOU, Apostolia M; COLBURN, Dawn E; WELCH, Mary Alma et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 3, pp 229-234, issn 0344-5704, 6 p.Article

Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: A report of two casesHASAN, Syed; HASSAN, Mohamed; OKE, Luc et al.Journal of the National Medical Association. 2003, Vol 95, Num 12, pp 1208-1210, issn 0027-9684, 3 p.Article

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemiaVAN DEVENTER, Hendrik W; HALL, Melissa D; ORLOWSKI, Robert Z et al.American journal of hematology. 2002, Vol 71, Num 3, pp 184-190, issn 0361-8609, 7 p.Article

Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progressionMARKTEL, Sarah; MARIN, David; OLAVARRIA, Eduardo et al.Haematologica (Roma). 2003, Vol 88, Num 3, pp 260-267, issn 0390-6078, 8 p.Article

Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patientsCERVANTES, Francisco; HERNANDEZ-BOIUDA, Juan-Carlos; ODRIOZOIA, Jesus et al.Haematologica (Roma). 2003, Vol 88, Num 10, pp 1117-1122, issn 0390-6078, 6 p.Article

Chronic myeloid leukemia patients resistant to or intolerant of interferon α and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemiaSTEEGMANN, Juan Luis; MORENO, Gemma; MUNOZ, Cecilia et al.Haematologica (Roma). 2003, Vol 88, Num 7, pp 762-768, issn 0390-6078, 7 p.Article

Polycythemia vera responds to imatinib mesylateJONES, C. Michael; DICKINSON, Tina Marie.The American journal of the medical sciences. 2003, Vol 325, Num 3, pp 149-152, issn 0002-9629, 4 p.Article

Eosinophilia : secondary, clonal and idiopathicTEFFERI, Ayalew; PATNAIK, Mrinal M; PARDANANI, Animesh et al.British journal of haematology. 2006, Vol 133, Num 5, pp 468-492, issn 0007-1048, 25 p.Article

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersPARDANANI, Animesh; REEDER, Terra; PORRATA, Luis F et al.Blood. 2003, Vol 101, Num 9, pp 3391-3397, issn 0006-4971, 7 p.Article

A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABLONOZAWA, Masahiro; FUKUHARA, Takashi; TAKAHATA, Mutsumi et al.Annals of hematology (Print). 2003, Vol 82, Num 9, pp 593-595, issn 0939-5555, 3 p.Article

Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic statusFRATER, John L; TALLMAN, Martin S; VARIAKOJIS, Daina et al.American journal of clinical pathology. 2003, Vol 119, Num 6, pp 833-841, issn 0002-9173, 9 p.Article

Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agentsPANDIELLA, Atanasio; CARVAJAL-VERGARA, Xonia; TABERA, Soraya et al.British journal of haematology. 2003, Vol 123, Num 5, pp 858-868, issn 0007-1048, 11 p.Article

Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cellsRAPOPORT, A. P; LEVINE, B. L; MANN, D et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 1, pp 53-60, issn 0268-3369, 8 p.Article

Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatmentKIM, Y-J; KIM, D-W; LEE, S et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 2, pp 237-242, issn 0268-3369, 6 p.Article

Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylateBARBOUTI, Aikaterini; AHLGREN, Tomas; JOHANSSON, Bertil et al.British journal of haematology. 2003, Vol 122, Num 1, pp 85-93, issn 0007-1048, 9 p.Article

Current therapy of chronic myelogenous leukemiaGARCIA-MANERO, Guillermo; TALPAZ, Moshe; KANTARJIAN, Hagop M et al.Internal medicine (Tokyo. 1992). 2002, Vol 41, Num 4, pp 254-264, issn 0918-2918Article

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfaMARIN, D; MARKTEL, S; LENNARD, A et al.Leukemia. 2003, Vol 17, Num 8, pp 1448-1453, issn 0887-6924, 6 p.Article

Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: A case reportTAN, D; HWANG, W; NG, H. J et al.International journal of hematology. 2004, Vol 80, Num 1, pp 75-77, issn 0925-5710, 3 p.Article

A report of three patients treated with Immunocell therapy with imatinib mesylateKANEKO, Toru; GOTO, Shigenori; KUSHIMA, Yoshiaki et al.Anticancer research. 2004, Vol 24, Num 5C, pp 3303-3309, issn 0250-7005, 7 p.Conference Paper

Transplantation for chronic myelogenous leukemia: yes, no, maybe so... an Oregon perspectiveMAZIARZ, Richard T; MAURO, Michael J.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 5, pp 459-469, issn 0268-3369, 11 p.Article

Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic responseCARIANI, E; CAPUCCI, M; MICHELETTI, M et al.Annals of hematology (Print). 2003, Vol 82, Num 6, pp 333-335, issn 0939-5555, 3 p.Article

Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocationO'BRIEN, Stephen G; VIEIRA, Sara A. D; CONNORS, Samantha et al.Blood. 2002, Vol 99, Num 9, pp 3465-3467, issn 0006-4971Article

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remissionDRUMMOND, Mark W; MARIN, David; CLARK, Richard E et al.British journal of haematology. 2003, Vol 123, Num 3, pp 479-483, issn 0007-1048, 5 p.Article

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administrationSANG KYUN SOHN; JONG GWANG KIM; DONG HWAN KIM et al.British journal of haematology. 2003, Vol 121, Num 3, pp 469-472, issn 0007-1048, 4 p.Article